Use of Echocardiography in Patients with Hypertrophic Cardiomyopathy: Clinical Implications of Massive Hypertrophy

Paul Sorajja, Rick A. Nishimura, Steve R. Ommen, Michael John Ackerman, A. Jamil Tajik, Bernard J. Gersh

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

We examined the 10-year outcome of 107 patients with hypertrophic cardiomyopathy and massive myocardial hypertrophy as assessed by echocardiography. These patients demonstrated excess mortality in comparison with their expected survival with respect to a general population of individuals (10-year survival 77% vs 95%, P < .001). Adverse events occurred primarily in the youngest and oldest patients. Sudden cardiac death was the most frequent cause of death among the young (overall survival 80%), whereas other causes predominated in older patients (overall survival 31%). For patients aged 30 to 59 years, survival was 97%, no different from their expected survival. Patients with hypertrophic cardiomyopathy and massive hypertrophy identified by echocardiography are at increased risk of death, but this risk is related to age at presentation. Sudden cardiac death is the primary cause in those who are young, whereas other causes predominate in older patients. Middle-aged patients with massive hypertrophy do not experience an excess mortality.

Original languageEnglish (US)
Pages (from-to)788-795
Number of pages8
JournalJournal of the American Society of Echocardiography
Volume19
Issue number6
DOIs
StatePublished - Jun 2006

Fingerprint

Hypertrophic Cardiomyopathy
Hypertrophy
Echocardiography
Survival
Sudden Cardiac Death
Mortality
Cause of Death
Population

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Radiology Nuclear Medicine and imaging

Cite this

Use of Echocardiography in Patients with Hypertrophic Cardiomyopathy : Clinical Implications of Massive Hypertrophy. / Sorajja, Paul; Nishimura, Rick A.; Ommen, Steve R.; Ackerman, Michael John; Tajik, A. Jamil; Gersh, Bernard J.

In: Journal of the American Society of Echocardiography, Vol. 19, No. 6, 06.2006, p. 788-795.

Research output: Contribution to journalArticle

Sorajja, Paul ; Nishimura, Rick A. ; Ommen, Steve R. ; Ackerman, Michael John ; Tajik, A. Jamil ; Gersh, Bernard J. / Use of Echocardiography in Patients with Hypertrophic Cardiomyopathy : Clinical Implications of Massive Hypertrophy. In: Journal of the American Society of Echocardiography. 2006 ; Vol. 19, No. 6. pp. 788-795.
@article{62763cba58af47b7830855ee0e4cff9d,
title = "Use of Echocardiography in Patients with Hypertrophic Cardiomyopathy: Clinical Implications of Massive Hypertrophy",
abstract = "We examined the 10-year outcome of 107 patients with hypertrophic cardiomyopathy and massive myocardial hypertrophy as assessed by echocardiography. These patients demonstrated excess mortality in comparison with their expected survival with respect to a general population of individuals (10-year survival 77{\%} vs 95{\%}, P < .001). Adverse events occurred primarily in the youngest and oldest patients. Sudden cardiac death was the most frequent cause of death among the young (overall survival 80{\%}), whereas other causes predominated in older patients (overall survival 31{\%}). For patients aged 30 to 59 years, survival was 97{\%}, no different from their expected survival. Patients with hypertrophic cardiomyopathy and massive hypertrophy identified by echocardiography are at increased risk of death, but this risk is related to age at presentation. Sudden cardiac death is the primary cause in those who are young, whereas other causes predominate in older patients. Middle-aged patients with massive hypertrophy do not experience an excess mortality.",
author = "Paul Sorajja and Nishimura, {Rick A.} and Ommen, {Steve R.} and Ackerman, {Michael John} and Tajik, {A. Jamil} and Gersh, {Bernard J.}",
year = "2006",
month = "6",
doi = "10.1016/j.echo.2006.01.005",
language = "English (US)",
volume = "19",
pages = "788--795",
journal = "Journal of the American Society of Echocardiography",
issn = "0894-7317",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Use of Echocardiography in Patients with Hypertrophic Cardiomyopathy

T2 - Clinical Implications of Massive Hypertrophy

AU - Sorajja, Paul

AU - Nishimura, Rick A.

AU - Ommen, Steve R.

AU - Ackerman, Michael John

AU - Tajik, A. Jamil

AU - Gersh, Bernard J.

PY - 2006/6

Y1 - 2006/6

N2 - We examined the 10-year outcome of 107 patients with hypertrophic cardiomyopathy and massive myocardial hypertrophy as assessed by echocardiography. These patients demonstrated excess mortality in comparison with their expected survival with respect to a general population of individuals (10-year survival 77% vs 95%, P < .001). Adverse events occurred primarily in the youngest and oldest patients. Sudden cardiac death was the most frequent cause of death among the young (overall survival 80%), whereas other causes predominated in older patients (overall survival 31%). For patients aged 30 to 59 years, survival was 97%, no different from their expected survival. Patients with hypertrophic cardiomyopathy and massive hypertrophy identified by echocardiography are at increased risk of death, but this risk is related to age at presentation. Sudden cardiac death is the primary cause in those who are young, whereas other causes predominate in older patients. Middle-aged patients with massive hypertrophy do not experience an excess mortality.

AB - We examined the 10-year outcome of 107 patients with hypertrophic cardiomyopathy and massive myocardial hypertrophy as assessed by echocardiography. These patients demonstrated excess mortality in comparison with their expected survival with respect to a general population of individuals (10-year survival 77% vs 95%, P < .001). Adverse events occurred primarily in the youngest and oldest patients. Sudden cardiac death was the most frequent cause of death among the young (overall survival 80%), whereas other causes predominated in older patients (overall survival 31%). For patients aged 30 to 59 years, survival was 97%, no different from their expected survival. Patients with hypertrophic cardiomyopathy and massive hypertrophy identified by echocardiography are at increased risk of death, but this risk is related to age at presentation. Sudden cardiac death is the primary cause in those who are young, whereas other causes predominate in older patients. Middle-aged patients with massive hypertrophy do not experience an excess mortality.

UR - http://www.scopus.com/inward/record.url?scp=33744514600&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33744514600&partnerID=8YFLogxK

U2 - 10.1016/j.echo.2006.01.005

DO - 10.1016/j.echo.2006.01.005

M3 - Article

C2 - 16762758

AN - SCOPUS:33744514600

VL - 19

SP - 788

EP - 795

JO - Journal of the American Society of Echocardiography

JF - Journal of the American Society of Echocardiography

SN - 0894-7317

IS - 6

ER -